102573-84-2

Basic information

• Product Name: 1,3-Dioxane-5-carboxaldehyde, 2,2-dimethyl- (9CI)
• Synonyms: 1,3-Dioxane-5-carboxaldehyde, 2,2-dimethyl- (9CI);1,3-Dioxane-5-carboxaldehyde, 2,2-diMethyl-;2,2-DiMethyl-[1,3]dioxane-5-carbaldehyde
• CAS NO: 102573-84-2
• Molecular Formula: C₇H₁₂O₃
• Molecular Weight: 144.16838
• Product Categories: ALDEHYDE
• Mol File: 102573-84-2.mol
• Article Data: 14

Chemical Properties

• Boiling Point: 194.6±25.0 °C(Predicted)
• Appearance: /
• Density: 1.079±0.06 g/cm3(Predicted)
• CAS DataBase Reference: 1,3-Dioxane-5-carboxaldehyde, 2,2-dimethyl- (9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: 1,3-Dioxane-5-carboxaldehyde, 2,2-dimethyl- (9CI)(102573-84-2)
• EPA Substance Registry System: 1,3-Dioxane-5-carboxaldehyde, 2,2-dimethyl- (9CI)(102573-84-2)

Safety Data

• Hazardous Substances Data: 102573-84-2(Hazardous Substances Data)

Usage

General Description

1,3-Dioxane-5-carboxaldehyde, 2,2-dimethyl- (9CI) is a chemical compound that belongs to the class of aldehydes. It is a clear, colorless liquid with a strong, sweet odor. 1,3-Dioxane-5-carboxaldehyde, 2,2-dimethyl- (9CI) is mainly used as an intermediate for the synthesis of pheromones and other chemical derivatives. It is also used in research and industrial applications as a building block in the production of various materials such as adhesives, polymers, and pharmaceuticals. However, 1,3-Dioxane-5-carboxaldehyde, 2,2-dimethyl- (9CI) is considered to be potentially hazardous and should be handled with caution due to its potential health risks and environmental impact.

Upstream product

• 4728-12-5 2,2-dimethyl-5-hydroxymethyl-1,3-dioxane 

Downstream Products

• 1395878-12-2 C₃₈H₄₂F₃NO₉ 
• 1395878-11-1 C₃₈H₄₂F₃NO₉ 
• 1395877-94-7 C₂₈H₃₅NO₇ 
• 1039747-49-3 C₂₈H₃₇N₃O₂ 
• 1029623-88-8 C₂₇H₃₆N₄O₂ 
• 1231170-13-0 1-(2,2-dimethyl-[1,3]dioxan-5-ylmethyl)-4-(4-trifluoromethoxyphenyl)piperazine 
• 155818-06-7 {(1S,2S)-2-[(E)-2-(2,2-Dimethyl-[1,3]dioxan-5-yl)-vinyl]-1,3-dimethyl-4-triisopropylsilanyloxy-cyclohex-3-enyl}-methanol 
• 155818-05-6 (1S,2R)-2-[(E)-2-(2,2-Dimethyl-[1,3]dioxan-5-yl)-vinyl]-1,3-dimethyl-4-triisopropylsilanyloxy-cyclohex-3-enecarbaldehyde 
• 155818-07-8 (S)-3-[(E)-2-(2,2-Dimethyl-[1,3]dioxan-5-yl)-vinyl]-4-hydroxymethyl-2,4-dimethyl-cyclohex-2-enone 
• 141081-72-3 (Rs)-2,2-dimethyl-5-<3-oxo-4-(p-tolylsulfinyl)butyl>-1,3-dioxane 
• 364330-78-9 4-(tert-butyl-dimethyl-silanyloxy)-2-[2-(2,2-dimethyl-[1,3]dioxan-5-yl)-vinyl]-1,3-dimethyl-cyclohexa-2,4-dienecarboxylic acid methyl ester 
• 364330-79-0 {4-(tert-butyl-dimethyl-silanyloxy)-2-[2-(2,2-dimethyl-[1,3]dioxan-5-yl)-vinyl]-1,3-dimethyl-cyclohexa-2,4-dienyl}-methanol 
• 364330-80-3 3-[(E)-2-(2,2-Dimethyl-[1,3]dioxan-5-yl)-vinyl]-4-hydroxymethyl-2,4-dimethyl-cyclohex-2-enone 
• 355423-31-3 2-[(E)-2-(2,2-Dimethyl-[1,3]dioxan-5-yl)-vinyl]-1,3-dimethyl-4-oxo-cyclohex-2-enecarboxylic acid methyl ester 

Relevant articles and documents

COMPOUNDS AND USES THEREOF

The present invention features compounds useful in the treatment of neurological disorders. The compounds of the invention, alone or in combination with other pharmaceutically active agents, can be used for treating or preventing neurological disorders.

ANTI-B7-H3 ANTIBODIES AND ANTIBODY DRUG CONJUGATES

The invention relates to B7 homology 3 protein (B7-H3) antibodies and antibody drug conjugates (ADCs), including compositions and methods of using said antibodies and ADCs.

ANTIBACTERIAL AGENTS

Antibacterial compounds of formula (I) are provided, as well as stereoisomers and pharmaceutically acceptable salts thereof; pharmaceutical compositions comprising such compounds; methods of treating bacterial infections by the administration of such compounds; and processes for the preparation of such compounds.